Glenmark Pharmaceuticals Inc., USA 2023-12-06 Health serious FDA
Health · FDA · Recall #FDA-D-0124-2024
Naproxen Tablets, USP 250mg, 100-count bottle, Rx Only, Manufactured by: Glenmark… Recall
Issued December 6, 2023 · Glenmark Pharmaceuticals Inc., USA
In December 2023, Glenmark Pharmaceuticals Inc., USA recalled the Naproxen Tablets, USP 250mg, 100-count bottle, Rx Only, Manufactured by: Glenmark…, a serious health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Labeling: Label Mix-Up-Indomethacin bottles may be labeled as Naproxen
What you should do
- 1 Stop using Naproxen Tablets, USP 250mg, 100-count bottle, Rx Only, Manufactured by: Glenmark… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Glenmark Pharmaceuticals Inc., USA to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Glenmark Pharmaceuticals Inc., USA
- Category
- Health
- Recall date
- December 6, 2023
- Units affected
- Not reported
- Sold at
- Nationwide
- Recall number
- FDA-D-0124-2024
- Made in
- United States
- Issuing agency
- FDA
In context
- Glenmark Pharmaceuticals Inc., USA has 53 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.